Status:
COMPLETED
The Clinical Value of Chromoendoscopy as Surveillance Strategy for Dysplasia Detection in Ulcerative Colitis
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Conditions:
Ulcerative Colitis
Chromoendoscopy
Eligibility:
All Genders
18+ years
Brief Summary
A recent multicentre randomised controlled trial compared autofluorescence imaging (AFI) with CE for dysplasia detection in colonoscopy surveillance of patients with longstanding UC (FIND-UC). In this...
Eligibility Criteria
Inclusion
- Patients are eligible for inclusion in this study when they meet the following criteria:
- Inclusion criteria
- In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- \- Patients that where included in the previous FIND-UC trial
- Exclusion criteria
- A potential subject who meets any of the following criteria will be excluded from participation in this study:
- Patients who not receive their surveillance colonoscopy with CE
- Patients who not undergo their surveillance colonoscopy within 3 months of the surveillance recommendations
- Withdrawal of individual subjects
- A patient will be excluded from the study if any of the following events occur:
- Withdrawal of informed consent
- The patient requests to be discontinued from the study
- The bowel preparation is scored as Boston Bowel Preparation Scale \<6
- Incomplete colonoscopy because the endoscopist is unable to intubate the cecum during the colonoscopy
- The Mayo-score \> 1 in at least in one of the bowel segments
Exclusion
Key Trial Info
Start Date :
May 9 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2018
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT03824418
Start Date
May 9 2016
End Date
October 1 2018
Last Update
January 31 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Academic Medical Centre
Amsterdam, North Holland, Netherlands, 1105AZ